Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
| Image |  |
|---|---|
| Description | scientific article published on 26 May 2016 |
| Author/s | |
| Publication date | May 26, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |